Placebo semaglutide
Placebo semaglutide is a pharmaceutical drug with 38 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 32 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
3
Mid Stage
29
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
32 of 32 finished
0.0%
0 ended early
5
trials recruiting
38
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
Clinical Trials (38)
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes
Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range
A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)
Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight
Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes
A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 38